📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. (2015)

First Author: Tuohy O

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2014-307721

PubMed Identifier: 24849515

Publication URI: http://europepmc.org/abstract/MED/24849515

Type: Journal Article/Review

Volume: 86

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 2

ISSN: 0022-3050